(IN BRIEF) ZEISS Medical Technology will present a range of new innovations at ASCRS 2026, focusing on improving ophthalmic workflows across cataract, refractive, and retinal care. The company will introduce new surgical tools compatible with the DORC EVA NEXUS system, … Read the full press release →
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Ireland, Management, Marketing, Science, Technology
Tagged Advanced Workflow and Cloud Based Care Solutions Highlight ZEISS Innovation Strategy in Ophthalmology, AI healthcare, ASCRS 2026, cataract surgery, cloud healthcare, digital health, DORC EVA NEXUS, Dr Dan Haddad, Magnus Reibenspiess, medical devices, MicroSurgical Technology, ophthalmology technology, patient engagement, ZEISS CLINIC 360, ZEISS Collaborative Care, ZEISS Introduces Next Generation Cataract and Patient Engagement Technologies at ASCRS Conference, ZEISS IOLMaster 700, ZEISS Medical Technology, ZEISS VERACITY Surgery Planner, ZEISS VisioGen
(IN BRIEF) GSK has entered into a multi-programme development and licensing agreement with Hengrui Pharma to advance up to 12 innovative therapies, including HRS-9821, a potentially best-in-class PDE3/4 inhibitor currently in clinical trials for COPD. The deal includes $500 million … Read the full press release →
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AI-era medicine, biopharma partnership, Chronic obstructive pulmonary disease, clinical development, cloud healthcare, COPD treatment, drug innovation, drug pipeline, dry powder inhaler, Frank Jiang, global health, GSK, Hart-Scott-Rodino Act, Hengrui Pharma, HRS-9821, immunology, inflammation, licensing agreement, milestone payments, novel therapeutics, oncology, partnership, PDE3/4 inhibitor, pharmaceutical collaboration, phase I trials, respiratory medicine, Tony Wood
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
